Ipilimumab-Induced Colitis on FDG PET/CT

被引：23
|
作者：
Lyall, Ashima [1 ]
Vargas, Herbert Alberto [1 ]
Carvajal, Richard D. [1 ]
Ulaner, Gary [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, Dept Radiol, New York, NY 10065 USA
来源：
CLINICAL NUCLEAR MEDICINE | 2012年 / 37卷 / 06期
关键词：
ipilimumab; colitis; FDG; ANTI-CTLA-4; ANTIBODY; MELANOMA; CTLA-4;
D O I：
10.1097/RLU.0b013e318248549a
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
A 52-year-old woman with metastatic melanoma was treated with ipilimumab. After 2 cycles of treatment, she developed watery diarrhea, sweats, and chills. An FDG PET/CT study demonstrated new FDG-avid (maximum standardized uptake value 15.6) diffuse colonic wall thickening, suggestive of ipilimumab-induced colitis. The patient was treated with systemic steroids, with subsequent resolution of her symptoms. Based on the response to steroids, the diagnosis of ipilimumab-induced enterocolitis was made. Ipilimumab may cause several immune-mediated toxicities, the most common of which is enterocolitis. Physicians interpreting FDG PET/CT examinations of patients treated with ipilimumab should be aware of these FDG-avid immune-mediated toxicities. © 2012 by Lippincott Williams & Wilkins.
引用
收藏
页码：629 / 630
页数：2
相关论文
共 50 条
  • [21] Ipilimumab-induced colitis: experience from a tertiary referral center
    O'Connor, Anthony
    Marples, Maria
    Mulatero, Clive
    Hamlin, John
    Ford, Alexander C.
    [J]. THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2016, 9 (04): : 457 - 462
  • [22] Management of Ipilimumab-Induced Colitis with Concurrent Clostridium difficile Infection
    Martinez-Balzano, Carlos
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 : S468 - S468
  • [23] Ipilimumab-Induced Hypophysitis
    Usama, Muhammad
    Mir, Tanveer
    Fida, Ania
    Mohsin, Syed Umer
    Ali, Hammad
    Raziq, Fazal I.
    Khan, Muhammad Shayan
    Levine, Diane
    [J]. AMERICAN JOURNAL OF THERAPEUTICS, 2021, 28 (06) : E761 - E763
  • [24] Infliximab Therapy for Corticosteroid-Resistant Ipilimumab-Induced Colitis
    Beniwal-Patel, Poonam
    Matkowskyj, Kristina
    Caldera, Freddy
    [J]. JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2015, 24 (03) : 274 - 274
  • [25] CMV Reactivation as the Cause of a steroid refractory Ipilimumab-induced Colitis
    Amschler, K.
    Diering, N.
    Ghazal, P.
    Mitterlechner, L.
    Schoen, M.
    Kretschmer, L.
    Thoms, K.
    [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2016, 14 : 47 - 48
  • [26] A Severe Case of Ipilimumab-Induced Guillain-Barre Syndrome Revealed by an Occlusive Enteric Neuropathy: A Differential Diagnosis for Ipilimumab-Induced Colitis
    Gaudy-Marqueste, Caroline
    Monestier, Sandrine
    Franques, Jerome
    Cantais, Emmanuel
    Richard, Marie-Aleth
    Grob, Jean-Jacques
    [J]. JOURNAL OF IMMUNOTHERAPY, 2013, 36 (01) : 77 - 78
  • [27] Ipilimumab-Induced Autoimmune Colitis: A Case Series of an Emerging Clinical Entity
    Klair, Jagpal
    Girotra, Mohit
    Kaur, Aneet
    Garcia-Saenz-de-Sicilia, Mauricio
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 : S407 - S407
  • [28] Endoscopic Remission After Infliximab Treatment in a Patient with Ipilimumab-Induced Colitis
    Ryan, Daniel
    Pasupuleti, Chitralekha
    Butnariu, Madalina
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S812 - S812
  • [29] Ipilimumab-Induced Neutropenia in Melanoma
    Ban-Hoefen, Makiko
    Burack, Richard
    Sievert, Lynn
    Sahasrabudhe, Deepak
    [J]. JOURNAL OF INVESTIGATIVE MEDICINE HIGH IMPACT CASE REPORTS, 2016, 4 (03):
  • [30] Ipilimumab-induced toxicities and the gastroenterologist
    Cheng, Robert
    Cooper, Adam
    Kench, James
    Watson, Geoff
    Bye, William
    McNeil, Catriona
    Shackel, Nicholas
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 30 (04) : 657 - 666
12345